Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday, 20th May, 2026 at 16:00 IST ....
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nephrocare Health Services Ltd has scheduled its Q4FY26 Earnings Conference Call for Wednesday, May 20, 2026 at 16:00 IST. The call will discuss the company's audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Key management including Chairman & MD Mr. Vikram Vuppala, Co-Founder Mr. Kamal Shah, Group CEO Mr. Rohit Singh, and Group CFO Mr. Prashant Goenka will participate. The company has clarified that no unpublished price sensitive information (UPSI) will be discussed during the call. ICICI Securities is coordinating the call.
This is a routine regulatory disclosure informing investors of an upcoming earnings call. No material developments or financial results are being announced at this time. The disclosure confirms management engagement with analysts and investors post-Q4FY26 results.